Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Needham analyst Mike Matson upgraded the rating for Haemonetics Corporation (NYSE:HAE) from Hold to Buy and announced a price target of $112. Haemonetics shares fell 2.8% to close at $83.41 on Tuesday. See how other analysts view this stock.
• Morgan Stanley analyst Meta Marshall upgraded Ciena Corporation (NYSE:CIEN) from Equal-Weight to Overweight, while raising the price target from $53 to $55. Ciena shares rose 0.2% to settle at $45.92 on Tuesday. See how other analysts view this stock.
• Citigroup analyst Thomas Palmer upgraded McCormick & Company, Incorporated (NYSE:MKC) from Sell to Neutral and increased the price target from $68 to $69. McCormick shares rose 1.6% to settle at $69.20 on Tuesday. See how other analysts view this stock. See how other analysts view this stock.
• Barclays analyst Raimo Lenschow upgraded the rating for Klaviyo, Inc. (NYSE:KVYO) from Equal-Weight to Overweight, while boosting the price target from $25 to $29. Klaviyo shares rose 0.1% to close at $22.58 on Tuesday. See how other analysts view this stock.
• Citigroup analyst Thomas Palmer upgraded Darling Ingredients Inc. (NYSE:DAR) from Neutral to Buy and announced a price target of $48. Darling Ingredients shares fell 1.5% to settle at $37.34 on Tuesday. See how other analysts view this stock.